Portola Pharma (PTLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2017 | 06-2017 | 03-2017 | 12-2016 | 09-2016 | |
| Sales | 3,828 | 3,787 | 5,128 | 13,693 | 9,322 |
| Cost of Goods | 155 | N/A | N/A | N/A | N/A |
| Gross Profit | 3,673 | 3,787 | 5,128 | 13,693 | 9,322 |
| Operating Expenses | 84,284 | 69,621 | 45,666 | 68,893 | 100,765 |
| Operating Income | -80,456 | -65,834 | -40,538 | -55,200 | -91,443 |
| Interest Expense | 3,148 | 3,456 | 1,639 | 0 | 0 |
| Other Income | 663 | -124 | 413 | 436 | 407 |
| Pre-tax Income | -82,941 | -69,414 | -41,764 | -54,764 | -91,036 |
| Net Income Continuous | -82,941 | -69,414 | -41,764 | -54,764 | -91,036 |
| Minority Interests | -5 | 240 | -45 | -923 | 1,853 |
| Net Income | $-82,936 | $-69,654 | $-41,719 | $-53,841 | $-92,889 |
| EPS Basic Total Ops | -1.41 | -1.22 | -0.74 | -0.95 | -1.64 |
| EPS Basic Continuous Ops | -1.41 | -1.22 | -0.74 | -0.97 | -1.61 |
| EPS Diluted Total Ops | -1.41 | -1.22 | -0.74 | -0.95 | -1.64 |
| EPS Diluted Continuous Ops | -1.41 | -1.22 | -0.74 | -0.97 | -1.61 |
| EBITDA(a) | $-79,824 | $-65,247 | $-39,873 | $-54,548 | $-90,743 |